1. Risk and temporal changes of heart failure among 5-year childhood cancer survivors: a DCOG-LATER study;Feijen;J Am Heart Assoc,2019
2. Cardiac disease in childhood cancer survivors: risk prediction, prevention, and surveillance: JACC CardioOncology state-of-the-art review;Leerink;J Am Coll Cardiol CardioOnc,2020
3. Genetics of anthracycline cardiomyopathy in cancer survivors: JACC: CardioOncology state-of-the-art review;Bhatia;J Am Coll Cardiol CardioOnc,2020
4. Candidate gene association studies of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis;Leong;Sci Rep,2017
5. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group;Ehrhardt;Lancet Oncol,2023